The Case ∣ Hypocalcemia, chronic renal failure and dysmorphism?  by Burtey, Stéphane et al.
Kidney International (2008) 74, 1495–1496; doi:10.1038/ki.2008.430
The Case | Hypocalcemia, chronic renal failure and
dysmorphism
Ste´phane Burtey1, Bertrand Dussol1, Nicole Philip2 and Yvon Berland1
1Centre de ne´phrologie et transplantation re´nale, Hopital de la conception, AP-HM, Universite´ de la Me´diterrane´e, Marseille, France and
2Service de Ge´ne´tique me´dicale, Hopital de la Timone, AP-HM, Universite´ de la Me´diterrane´e, Marseille, France
Correspondence: Ste´phane Burtey, Centre de ne´phrologie et transplantation re´nale, Hopital de la conception, 147 bd Baille, 13005
Marseille, France. E-mail: stephaneb@ap-hm.fr
A 42-year-old man was referred with seizures related to
hypocalcemia. He was born with sacral spina bifida, which
was operated at the age of 13 years with subsequent anal
incontinence. His early life was notable for subnormal
psychomotor development, severe learning disabilities, beha-
vioral abnormalities and his intelligence quotient was
measured to be 62. At 36 years of age, he developed dilated
cardiomyopathy leading to heart failure and chronic kidney
disease was also diagnosed at that time. The renal
insufficiency was related to a bilateral kidney hypoplasia
(kidney sizes: left: 6 cm, right: 5.5 cm). There was no
vesicoureteral reflux or hydronephrosis. The patient was also
noted to be severely hypocalcemic (1.4 mmol/l). The
hypocalcemia was very difficult to control because of poor
compliance with medications.
On admission, the patient was confused. Clinical exam-
ination revealed subtle dysmorphic features with a long face,
small mouth, prominent nasal bridge, narrow palpebral
fissures, and small ears without lobules (Figure 1). He was
noted to have nasal speech.
Laboratory abnormalities include serum calcium
1.24 mmol/l (normal 2.2–2.6); phosphorus 2.2 mmol/l (nor-
mal 0.8–1.45); bicarbonate 16 mmol/l (normal 22–28);
creatinine 360 mmol/l (normal 65–120, GFR¼ 24 ml/min
per 1.73 m2); albumin levels 38 g/l (normal 35–45); para-
thormone 17 pg/ml (normal 10–55); 25-OH D3 8 ng/ml
(normal 16–38); and 1,25-OH D3 22 ng/ml (normal 18–62).
Urinary calcium was 0.2 mmol/l.
A cerebral computed tomography scan was normal.
The hypocalcemia appeared to be related to hypoparathyroidism.
What is the cause of his hypoparathyroidism and chronic renal failure?
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Figure 1 | Facial dysmorphism.
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The Diagnosis | 22q11.2 deletion syndrome
(OMIM no. 188400)
The clinical suspicion was confirmed by a fluorescent in situ
hybridization analysis (Figure 2). The hypocalcemia was
easily corrected by oral calcium (calcium carbonate between
3 and 6 g/day) and vitamin D supplementation (calcifediol
100 mg/day for a month then 50 mg/day with calcitriol 0.5 mg/
day). The follow-up was notable for active psychiatric issues,
recurrent hypocalcemic events, and a progression to end stage
renal failure. No bony abnormalities such as Looser’s zones
or bone distortions were evidenced by standard X-ray
radiographs. No vascular calcifications were observed on a
chest and abdomen computed tomography scan. Hemodia-
lysis was begun 2 years after the diagnosis of 22q11.2 deletion
syndrome.
Microdeletion of chromosome 22q11.2 is the commonest
human deletion syndrome (1 in 4000 live births).1 The
microdeletion involves 20–30 genes. TBX1 is a member of a
phylogenetically conserved family of transcription factor,
T-box genes, involved in regulation of developmental process.
Its haplosufficiency is critical for the phenotype.1 Catechol-
O-methyl transferase gene is implicated in the behavioral and
psychiatric disturbances.
The main manifestations of the syndrome include palatal
anomalies such as cleft palate or velopharyngeal insufficiency,
conotruncal heart defects, hypocalcaemia, immune disorders,
and minor facial anomalies. Learning disabilities are frequent
and 15% of patients are prone to develop psychiatric disorders.
The phenotypic expression of the 22q11 microdeletion is highly
variable and ranges from severe life-threatening DiGeorge
syndrome to nearly asymptomatic affected individuals. The
mode of inheritance is autosomal dominant, with 95% of cases
being sporadic, because of de novo mutations.
In the majority of patients hypoparathryroidism is
frequently (70%) latent. Symptomatic hypocalcemia is
uncommon (10%) can occur during stress (surgery or
infection).2 Hypocalcemia is not uncommon during the
neonatal period and resolves spontaneously during the first
year of life. In our patient the severity of hypocalcemia was
related to hypoparathyroidism compounded by chronic renal
failure and vitamin D deficiency. The latter was related to
reduced sun exposure and poor nutritional status.
A total of 36% of the patients have abnormal kidneys1 and
the frequency of renal failure is 10% in adults.3 In adult
series, the most common abnormalities were hydronephrosis
(7.7%) and kidney agenesis (6%).3 In children hypoplasia or
agenesis of the kidney is the most common feature (17%).
Multicystic dysplasia (10%) and vesicoureteral reflux (4%)
have also been reported.1,4,5 The diagnosis of the 22q11.2
should be considered in patients with malformation of the
kidney.
Establishing a diagnosis of 22q11.2 deletion syndrome is
important for both genetic counseling and long-term manage-
ment of associated medical, surgical, and psychiatric conditions.
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Figure 2 | FISH analysis of the 22q11.2 microdeletion. The green dots mark the 22 chromosome. The red dot (Tuple probe) marks the
microdeleted region in 22q11.2 deletion syndrome. The hybridization is missing on one chromosome, confirming the deletion.
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